Adenosine A2A receptor

From WikiMD's WELLNESSPEDIA

Adenosine A2A receptor (A2AR) is a type of adenosine receptor that is encoded by the ADORA2A gene in humans. It is a G protein-coupled receptor that is involved in various physiological processes, including the regulation of myocardial oxygen consumption and coronary blood flow.

Structure[edit]

The A2AR is a member of the large superfamily of G protein-coupled receptors. It is characterized by seven transmembrane domains, an extracellular N-terminus, and an intracellular C-terminus. The receptor is coupled to the Gs alpha subunit, which, when activated, stimulates the production of cyclic AMP.

Function[edit]

The A2AR is highly expressed in the basal ganglia, a group of subcortical nuclei in the brain responsible for motor control and learning. It is also found in the immune system, where it plays a role in regulating immune response. Activation of the A2AR can have various effects, depending on the tissue and cell type. In the brain, it can modulate neurotransmitter release, while in the immune system, it can inhibit inflammatory responses.

Clinical significance[edit]

The A2AR has been implicated in a variety of diseases, including Parkinson's disease, schizophrenia, and chronic heart failure. It is also a target for potential treatments for these conditions. For example, A2AR antagonists are being investigated for their potential to improve motor symptoms in Parkinson's disease.

See also[edit]

References[edit]



This GPCR-related article is a stub. You can help WikiMD by expanding it.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.